In addition to these peptidomimetics of CDKN1A, SDCs, called 'dimerizers' [65], that induce or stabilize CDK2/cyclin A/CDKN1A protein complex could potentially lead to treatments for cancer. The gene discussed is CDK2; the disease is cancer.